Login / Signup

Use of anti-Parkinson medication during pregnancy: a case series.

Zeynep TüfekçioğluHaşmet HanağasıGül Yalçın ÇakmaklıBülent ElibolFigen Esmeli TokuçoğluZeynep Ece KayaSibel ErtanSibel ÖzekmekçiMurat Emre
Published in: Journal of neurology (2018)
Results in our case series suggest that levodopa, rasagiline, pramipexole, and ropinirole alone or in combination with each other may be considered relatively safe during pregnancy. Expected benefits and risks should be considered when prescribing anti-PD medication in pregnant women.
Keyphrases
  • pregnant women
  • adverse drug
  • healthcare
  • primary care
  • parkinson disease
  • deep brain stimulation
  • human health
  • emergency department
  • risk assessment
  • climate change
  • drug induced